| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Autoimmunity | 11 | 2024 | 169 | 4.310 |
Why?
|
| Diabetes Mellitus, Type 1 | 14 | 2023 | 565 | 3.000 |
Why?
|
| Microbiota | 7 | 2024 | 409 | 1.820 |
Why?
|
| Intestines | 7 | 2019 | 416 | 1.680 |
Why?
|
| Autoimmune Diseases | 6 | 2015 | 250 | 1.600 |
Why?
|
| Lupus Erythematosus, Systemic | 2 | 2024 | 212 | 1.600 |
Why?
|
| Immunity, Innate | 11 | 2019 | 434 | 1.530 |
Why?
|
| Androgens | 2 | 2024 | 175 | 1.300 |
Why?
|
| T-Lymphocytes | 16 | 2024 | 1221 | 1.270 |
Why?
|
| Intestinal Mucosa | 7 | 2019 | 806 | 1.210 |
Why?
|
| fas Receptor | 6 | 2014 | 77 | 1.200 |
Why?
|
| Immune Tolerance | 6 | 2020 | 341 | 1.160 |
Why?
|
| Mice | 65 | 2024 | 11858 | 1.140 |
Why?
|
| Mice, Inbred NOD | 14 | 2024 | 198 | 1.100 |
Why?
|
| Host-Pathogen Interactions | 5 | 2015 | 237 | 1.070 |
Why?
|
| Histocompatibility Antigens Class II | 10 | 2021 | 166 | 1.050 |
Why?
|
| Mammary Tumor Virus, Mouse | 12 | 2017 | 64 | 1.050 |
Why?
|
| Animals | 77 | 2024 | 27536 | 1.040 |
Why?
|
| Adaptive Immunity | 6 | 2019 | 167 | 0.990 |
Why?
|
| Fucose | 2 | 2015 | 13 | 0.980 |
Why?
|
| Metagenome | 4 | 2013 | 105 | 0.980 |
Why?
|
| Toll-Like Receptors | 4 | 2015 | 93 | 0.970 |
Why?
|
| Retroviridae Infections | 11 | 2023 | 48 | 0.950 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 22 | 1 | 2024 | 9 | 0.950 |
Why?
|
| Symbiosis | 3 | 2022 | 127 | 0.930 |
Why?
|
| Receptors, Androgen | 1 | 2024 | 119 | 0.890 |
Why?
|
| Bacteria | 8 | 2023 | 486 | 0.840 |
Why?
|
| Homeostasis | 4 | 2013 | 418 | 0.830 |
Why?
|
| Peyer's Patches | 4 | 2010 | 18 | 0.780 |
Why?
|
| Islets of Langerhans | 9 | 2020 | 549 | 0.770 |
Why?
|
| Disease Models, Animal | 3 | 2024 | 2395 | 0.750 |
Why?
|
| Dendritic Cells | 6 | 2019 | 451 | 0.710 |
Why?
|
| Mice, Knockout | 21 | 2024 | 2016 | 0.700 |
Why?
|
| Mice, Transgenic | 15 | 2014 | 1579 | 0.690 |
Why?
|
| Primates | 1 | 2021 | 155 | 0.660 |
Why?
|
| Sepsis | 2 | 2021 | 329 | 0.660 |
Why?
|
| Lymphocyte Activation | 9 | 2024 | 754 | 0.640 |
Why?
|
| Mice, Inbred C57BL | 22 | 2024 | 3253 | 0.620 |
Why?
|
| Insulin-Secreting Cells | 3 | 2012 | 408 | 0.590 |
Why?
|
| Gluconeogenesis | 1 | 2017 | 14 | 0.580 |
Why?
|
| Antigen Presentation | 7 | 2021 | 215 | 0.570 |
Why?
|
| Tumor Necrosis Factor-alpha | 5 | 2019 | 700 | 0.550 |
Why?
|
| Lymphocytic Choriomeningitis | 2 | 2014 | 9 | 0.520 |
Why?
|
| Models, Immunological | 2 | 2013 | 81 | 0.510 |
Why?
|
| B-Lymphocytes | 7 | 2007 | 740 | 0.490 |
Why?
|
| Germ-Free Life | 5 | 2024 | 77 | 0.490 |
Why?
|
| Lymphocytic choriomeningitis virus | 2 | 2014 | 14 | 0.480 |
Why?
|
| Bacterial Infections | 2 | 2013 | 184 | 0.460 |
Why?
|
| Gastrointestinal Tract | 2 | 2013 | 192 | 0.460 |
Why?
|
| T-Lymphocytes, Cytotoxic | 3 | 2012 | 319 | 0.460 |
Why?
|
| Antibodies, Neutralizing | 5 | 2020 | 123 | 0.460 |
Why?
|
| Disease | 1 | 2014 | 90 | 0.450 |
Why?
|
| Epithelium | 1 | 2014 | 323 | 0.440 |
Why?
|
| Intestine, Small | 2 | 2014 | 299 | 0.430 |
Why?
|
| Signal Transduction | 7 | 2024 | 3404 | 0.420 |
Why?
|
| Cytotoxicity, Immunologic | 4 | 2012 | 215 | 0.420 |
Why?
|
| CD8-Positive T-Lymphocytes | 6 | 2012 | 600 | 0.420 |
Why?
|
| Receptors, Immunologic | 3 | 2009 | 136 | 0.410 |
Why?
|
| Superantigens | 5 | 2004 | 24 | 0.410 |
Why?
|
| Interferon-gamma | 5 | 2018 | 449 | 0.410 |
Why?
|
| Macrophages | 3 | 2013 | 582 | 0.410 |
Why?
|
| Antigen-Presenting Cells | 5 | 2007 | 142 | 0.400 |
Why?
|
| Receptors, Complement | 1 | 2012 | 46 | 0.390 |
Why?
|
| Nobel Prize | 1 | 2011 | 10 | 0.390 |
Why?
|
| Early Diagnosis | 1 | 2012 | 126 | 0.380 |
Why?
|
| Retroviridae | 2 | 2022 | 79 | 0.380 |
Why?
|
| Diabetes Mellitus, Experimental | 3 | 2007 | 191 | 0.370 |
Why?
|
| Environment | 1 | 2013 | 225 | 0.370 |
Why?
|
| HLA-D Antigens | 3 | 2021 | 20 | 0.370 |
Why?
|
| Immune System | 1 | 2012 | 97 | 0.370 |
Why?
|
| Specific Pathogen-Free Organisms | 4 | 2024 | 78 | 0.360 |
Why?
|
| Antigens, Viral | 5 | 2011 | 145 | 0.360 |
Why?
|
| Gene Expression Regulation | 5 | 2014 | 1983 | 0.340 |
Why?
|
| Antigens, Bacterial | 1 | 2010 | 136 | 0.340 |
Why?
|
| Immunity, Mucosal | 3 | 2012 | 70 | 0.320 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 4 | 1998 | 20 | 0.320 |
Why?
|
| Histocompatibility Antigens Class I | 2 | 2010 | 201 | 0.310 |
Why?
|
| Epithelial Cells | 2 | 2010 | 689 | 0.310 |
Why?
|
| Sex Characteristics | 3 | 2024 | 328 | 0.300 |
Why?
|
| Peptides | 5 | 2021 | 649 | 0.290 |
Why?
|
| CD4-Positive T-Lymphocytes | 4 | 2019 | 450 | 0.290 |
Why?
|
| Female | 26 | 2024 | 46617 | 0.290 |
Why?
|
| Membrane Glycoproteins | 4 | 2004 | 432 | 0.280 |
Why?
|
| Lymphotoxin-alpha | 2 | 2004 | 44 | 0.280 |
Why?
|
| Toll-Like Receptor 4 | 5 | 2016 | 91 | 0.280 |
Why?
|
| Mice, Inbred BALB C | 10 | 2020 | 1091 | 0.270 |
Why?
|
| Male | 19 | 2024 | 42705 | 0.270 |
Why?
|
| Tumor Virus Infections | 7 | 2011 | 83 | 0.250 |
Why?
|
| Cells, Cultured | 8 | 2019 | 2887 | 0.250 |
Why?
|
| Immunity, Humoral | 2 | 2017 | 66 | 0.250 |
Why?
|
| Dendritic Cells, Follicular | 2 | 2004 | 20 | 0.250 |
Why?
|
| Insulin | 4 | 2010 | 1148 | 0.250 |
Why?
|
| Interleukins | 2 | 2016 | 132 | 0.240 |
Why?
|
| Humans | 26 | 2024 | 90014 | 0.240 |
Why?
|
| Antibodies, Viral | 4 | 2018 | 311 | 0.230 |
Why?
|
| Mice, SCID | 4 | 2012 | 259 | 0.230 |
Why?
|
| Adoptive Transfer | 5 | 2012 | 169 | 0.230 |
Why?
|
| Cell Movement | 3 | 2016 | 787 | 0.230 |
Why?
|
| T-Lymphocyte Subsets | 2 | 2006 | 276 | 0.230 |
Why?
|
| Major Histocompatibility Complex | 5 | 2019 | 84 | 0.230 |
Why?
|
| Mice, Inbred Strains | 6 | 2020 | 308 | 0.210 |
Why?
|
| Fas Ligand Protein | 5 | 2019 | 49 | 0.210 |
Why?
|
| T-Lymphocytes, Regulatory | 5 | 2010 | 312 | 0.210 |
Why?
|
| Chemotaxis | 1 | 2003 | 73 | 0.210 |
Why?
|
| Myeloid Differentiation Factor 88 | 2 | 2015 | 49 | 0.200 |
Why?
|
| Proteolysis | 1 | 2023 | 114 | 0.200 |
Why?
|
| Glutens | 1 | 2023 | 84 | 0.200 |
Why?
|
| Inflammation | 4 | 2019 | 981 | 0.190 |
Why?
|
| Mice, Inbred C3H | 8 | 2011 | 371 | 0.190 |
Why?
|
| Antigens, CD | 3 | 2003 | 466 | 0.180 |
Why?
|
| Viral Envelope Proteins | 3 | 2015 | 94 | 0.180 |
Why?
|
| Endosomes | 3 | 1997 | 79 | 0.180 |
Why?
|
| Sex Factors | 1 | 2024 | 1075 | 0.180 |
Why?
|
| Endothelium, Vascular | 1 | 2003 | 435 | 0.180 |
Why?
|
| Cell Differentiation | 2 | 2005 | 1533 | 0.180 |
Why?
|
| Leukemia | 1 | 2022 | 322 | 0.170 |
Why?
|
| Antibodies | 2 | 2021 | 353 | 0.170 |
Why?
|
| Pancreas, Exocrine | 1 | 2020 | 18 | 0.170 |
Why?
|
| Ligands | 3 | 2016 | 447 | 0.170 |
Why?
|
| Gene Deletion | 2 | 2014 | 340 | 0.170 |
Why?
|
| Microcirculation | 1 | 2020 | 105 | 0.170 |
Why?
|
| Diet | 1 | 2023 | 444 | 0.170 |
Why?
|
| Receptors, Antigen, T-Cell | 4 | 2021 | 395 | 0.170 |
Why?
|
| Interleukin-1beta | 1 | 2019 | 82 | 0.170 |
Why?
|
| Myeloid Cells | 1 | 2019 | 101 | 0.160 |
Why?
|
| Apoptosis | 3 | 2003 | 1718 | 0.160 |
Why?
|
| Rauscher Virus | 2 | 2017 | 8 | 0.160 |
Why?
|
| Polymorphism, Genetic | 2 | 2019 | 824 | 0.160 |
Why?
|
| Immunoglobulin G | 3 | 2018 | 469 | 0.150 |
Why?
|
| Gene Expression | 4 | 2019 | 1309 | 0.150 |
Why?
|
| Severity of Illness Index | 1 | 2024 | 1863 | 0.150 |
Why?
|
| Viruses | 1 | 2018 | 78 | 0.150 |
Why?
|
| Clone Cells | 5 | 2012 | 214 | 0.140 |
Why?
|
| Cell Line | 5 | 2014 | 2495 | 0.140 |
Why?
|
| Molecular Sequence Data | 5 | 2008 | 3024 | 0.140 |
Why?
|
| Glycosylation | 2 | 2014 | 128 | 0.140 |
Why?
|
| Phylogeny | 2 | 2015 | 1198 | 0.140 |
Why?
|
| Lymphoid Tissue | 3 | 2006 | 56 | 0.130 |
Why?
|
| Immunization | 1 | 2016 | 163 | 0.130 |
Why?
|
| Interleukin-23 | 1 | 2016 | 57 | 0.130 |
Why?
|
| Species Specificity | 3 | 2014 | 685 | 0.130 |
Why?
|
| Spleen | 5 | 2023 | 433 | 0.130 |
Why?
|
| Lipopolysaccharide Receptors | 1 | 2015 | 23 | 0.130 |
Why?
|
| Cell Polarity | 1 | 2016 | 116 | 0.130 |
Why?
|
| Immune Evasion | 2 | 2015 | 35 | 0.130 |
Why?
|
| Keratinocytes | 1 | 2016 | 146 | 0.130 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2015 | 50 | 0.120 |
Why?
|
| Obesity | 2 | 2014 | 972 | 0.120 |
Why?
|
| Glycine | 1 | 2005 | 96 | 0.120 |
Why?
|
| Cell Communication | 2 | 2012 | 200 | 0.120 |
Why?
|
| Citrobacter rodentium | 1 | 2014 | 14 | 0.120 |
Why?
|
| Protective Factors | 1 | 2014 | 23 | 0.120 |
Why?
|
| Fucosyltransferases | 1 | 2014 | 9 | 0.120 |
Why?
|
| Anorexia | 1 | 2014 | 28 | 0.120 |
Why?
|
| Anti-Infective Agents | 1 | 2015 | 91 | 0.120 |
Why?
|
| Cyclophosphamide | 1 | 2005 | 301 | 0.120 |
Why?
|
| Endocytosis | 2 | 1997 | 180 | 0.120 |
Why?
|
| Vero Cells | 1 | 2014 | 103 | 0.110 |
Why?
|
| Adjuvants, Immunologic | 1 | 2005 | 169 | 0.110 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2014 | 86 | 0.110 |
Why?
|
| Insulin Resistance | 2 | 2014 | 353 | 0.110 |
Why?
|
| Fatty Acids | 1 | 2014 | 134 | 0.110 |
Why?
|
| Virulence Factors | 1 | 2014 | 112 | 0.110 |
Why?
|
| Pancreas | 2 | 2007 | 253 | 0.110 |
Why?
|
| Communicable Diseases | 1 | 2014 | 63 | 0.110 |
Why?
|
| Antibodies, Monoclonal | 5 | 1998 | 1396 | 0.110 |
Why?
|
| Castration | 1 | 2013 | 37 | 0.110 |
Why?
|
| Eating | 1 | 2014 | 167 | 0.110 |
Why?
|
| Skin | 1 | 2016 | 589 | 0.100 |
Why?
|
| Transgenes | 2 | 2007 | 185 | 0.100 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2014 | 217 | 0.100 |
Why?
|
| Monocytes | 1 | 2014 | 221 | 0.100 |
Why?
|
| Pore Forming Cytotoxic Proteins | 1 | 2012 | 54 | 0.100 |
Why?
|
| Cell Survival | 2 | 2014 | 983 | 0.100 |
Why?
|
| Mice, Inbred CBA | 5 | 2004 | 53 | 0.100 |
Why?
|
| Caspase 1 | 2 | 2019 | 20 | 0.100 |
Why?
|
| Cell Compartmentation | 3 | 2004 | 70 | 0.100 |
Why?
|
| Immunomodulation | 1 | 2012 | 57 | 0.100 |
Why?
|
| Antigens | 2 | 2016 | 229 | 0.100 |
Why?
|
| Bacterial Physiological Phenomena | 1 | 2011 | 42 | 0.090 |
Why?
|
| Lymphocytes | 1 | 2013 | 468 | 0.090 |
Why?
|
| Inflammation Mediators | 1 | 2012 | 153 | 0.090 |
Why?
|
| Enteritis | 1 | 2010 | 21 | 0.090 |
Why?
|
| Chronic Disease | 1 | 2014 | 958 | 0.090 |
Why?
|
| Probiotics | 1 | 2012 | 89 | 0.090 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2010 | 35 | 0.090 |
Why?
|
| H-2 Antigens | 3 | 1987 | 58 | 0.090 |
Why?
|
| Muscle, Skeletal | 1 | 2014 | 471 | 0.090 |
Why?
|
| Ephrin-B2 | 1 | 2010 | 3 | 0.090 |
Why?
|
| History, 20th Century | 1 | 2011 | 315 | 0.090 |
Why?
|
| Pancreatitis | 1 | 2010 | 86 | 0.090 |
Why?
|
| Receptor, EphB4 | 1 | 2010 | 23 | 0.090 |
Why?
|
| Hybridomas | 2 | 1995 | 75 | 0.090 |
Why?
|
| Herpesvirus 2, Human | 1 | 2010 | 45 | 0.090 |
Why?
|
| Molecular Targeted Therapy | 1 | 2012 | 280 | 0.080 |
Why?
|
| Arteriovenous Malformations | 1 | 2010 | 45 | 0.080 |
Why?
|
| Mycoses | 1 | 2009 | 46 | 0.080 |
Why?
|
| Receptor, Notch1 | 1 | 2010 | 94 | 0.080 |
Why?
|
| RNA, Messenger | 3 | 2012 | 2026 | 0.080 |
Why?
|
| Amino Acids | 2 | 2009 | 246 | 0.080 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2012 | 346 | 0.080 |
Why?
|
| Hematopoiesis | 2 | 2016 | 168 | 0.080 |
Why?
|
| Fatty Liver | 1 | 2009 | 99 | 0.080 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2010 | 184 | 0.080 |
Why?
|
| Interleukin-2 | 1 | 2009 | 241 | 0.080 |
Why?
|
| Herpes Simplex | 1 | 2010 | 203 | 0.080 |
Why?
|
| Adipocytes | 1 | 2009 | 163 | 0.080 |
Why?
|
| Peptide Fragments | 1 | 2010 | 463 | 0.080 |
Why?
|
| Vaccination | 1 | 2010 | 279 | 0.080 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2005 | 1098 | 0.080 |
Why?
|
| Integrases | 1 | 2007 | 63 | 0.070 |
Why?
|
| CD11c Antigen | 1 | 2007 | 13 | 0.070 |
Why?
|
| Adipose Tissue | 1 | 2009 | 262 | 0.070 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 2007 | 133 | 0.070 |
Why?
|
| Green Fluorescent Proteins | 1 | 2007 | 309 | 0.070 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2006 | 90 | 0.070 |
Why?
|
| Chromosome Mapping | 2 | 2020 | 1074 | 0.070 |
Why?
|
| Leukemia Virus, Murine | 2 | 2023 | 18 | 0.070 |
Why?
|
| Interleukin-10 | 3 | 2015 | 155 | 0.070 |
Why?
|
| Lipopolysaccharides | 3 | 2015 | 295 | 0.060 |
Why?
|
| Virus Replication | 3 | 2011 | 326 | 0.060 |
Why?
|
| Genes, MHC Class I | 2 | 2003 | 48 | 0.060 |
Why?
|
| Dermatitis | 1 | 2005 | 34 | 0.060 |
Why?
|
| Receptors, Cell Surface | 2 | 2003 | 288 | 0.060 |
Why?
|
| RNA, Ribosomal, 16S | 2 | 2019 | 251 | 0.060 |
Why?
|
| Antineoplastic Agents | 1 | 2005 | 2331 | 0.060 |
Why?
|
| Glucose Transporter Type 2 | 1 | 2003 | 11 | 0.050 |
Why?
|
| Pertussis Toxin | 1 | 2003 | 31 | 0.050 |
Why?
|
| Endoglin | 1 | 2003 | 21 | 0.050 |
Why?
|
| Receptors, Chemokine | 1 | 2003 | 30 | 0.050 |
Why?
|
| Culture Techniques | 1 | 2003 | 91 | 0.050 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2003 | 5 | 0.050 |
Why?
|
| Protein Binding | 2 | 2015 | 1492 | 0.050 |
Why?
|
| Neutrophil Activation | 1 | 2003 | 11 | 0.050 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2003 | 56 | 0.050 |
Why?
|
| Monosaccharide Transport Proteins | 1 | 2003 | 73 | 0.050 |
Why?
|
| Endogenous Retroviruses | 1 | 2002 | 10 | 0.050 |
Why?
|
| Models, Biological | 1 | 2009 | 1766 | 0.050 |
Why?
|
| Metabolomics | 1 | 2023 | 76 | 0.050 |
Why?
|
| Crosses, Genetic | 4 | 2009 | 171 | 0.050 |
Why?
|
| Blotting, Western | 3 | 2014 | 793 | 0.050 |
Why?
|
| Lymphocyte Transfusion | 1 | 2001 | 41 | 0.050 |
Why?
|
| Cell Adhesion | 1 | 2003 | 426 | 0.050 |
Why?
|
| Injections, Intravenous | 1 | 2001 | 238 | 0.050 |
Why?
|
| Enterotoxins | 1 | 2001 | 22 | 0.050 |
Why?
|
| Base Sequence | 2 | 1995 | 2329 | 0.050 |
Why?
|
| Animals, Newborn | 3 | 2011 | 524 | 0.050 |
Why?
|
| Mice, Congenic | 1 | 2020 | 12 | 0.050 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2009 | 2415 | 0.050 |
Why?
|
| Carcinogenesis | 1 | 2022 | 216 | 0.040 |
Why?
|
| Lymphocyte Culture Test, Mixed | 4 | 1990 | 73 | 0.040 |
Why?
|
| Caspase 8 | 1 | 2019 | 34 | 0.040 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2001 | 127 | 0.040 |
Why?
|
| Defensins | 1 | 2019 | 5 | 0.040 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2019 | 43 | 0.040 |
Why?
|
| Membrane Proteins | 2 | 2006 | 1227 | 0.040 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 1999 | 141 | 0.040 |
Why?
|
| Capillaries | 1 | 2020 | 90 | 0.040 |
Why?
|
| Inflammasomes | 1 | 2019 | 26 | 0.040 |
Why?
|
| Immunohistochemistry | 2 | 2010 | 1801 | 0.040 |
Why?
|
| Time Factors | 1 | 2008 | 5361 | 0.040 |
Why?
|
| Cell Count | 1 | 1999 | 199 | 0.040 |
Why?
|
| Printing, Three-Dimensional | 1 | 2020 | 45 | 0.040 |
Why?
|
| Immunoglobulin M | 1 | 1999 | 164 | 0.040 |
Why?
|
| Genes, Immunoglobulin | 1 | 1999 | 111 | 0.040 |
Why?
|
| Principal Component Analysis | 1 | 2019 | 161 | 0.040 |
Why?
|
| Amino Acid Sequence | 2 | 2002 | 2064 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2020 | 1181 | 0.040 |
Why?
|
| Immunocompromised Host | 1 | 2019 | 142 | 0.040 |
Why?
|
| Lymph Nodes | 3 | 2016 | 550 | 0.040 |
Why?
|
| Drug Resistance | 2 | 1989 | 232 | 0.040 |
Why?
|
| Dimerization | 1 | 1998 | 143 | 0.040 |
Why?
|
| Genes, MHC Class II | 2 | 1997 | 30 | 0.040 |
Why?
|
| Thymus Gland | 2 | 1997 | 197 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 2 | 1995 | 100 | 0.040 |
Why?
|
| Staphylococcus aureus | 1 | 2001 | 278 | 0.040 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 1997 | 283 | 0.040 |
Why?
|
| Biological Transport | 2 | 1995 | 401 | 0.040 |
Why?
|
| Proteins | 1 | 2003 | 787 | 0.040 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2019 | 197 | 0.040 |
Why?
|
| Hepatitis B | 1 | 2017 | 76 | 0.030 |
Why?
|
| Rats | 3 | 1997 | 4048 | 0.030 |
Why?
|
| Transfection | 2 | 1997 | 909 | 0.030 |
Why?
|
| Epidermis | 1 | 2016 | 102 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2017 | 515 | 0.030 |
Why?
|
| Clonal Deletion | 1 | 1995 | 23 | 0.030 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 1995 | 97 | 0.030 |
Why?
|
| Protein Conformation | 1 | 1998 | 895 | 0.030 |
Why?
|
| Lectins, C-Type | 1 | 1995 | 86 | 0.030 |
Why?
|
| CD40 Antigens | 1 | 1995 | 44 | 0.030 |
Why?
|
| Hepatitis C | 1 | 2017 | 174 | 0.030 |
Why?
|
| CD40 Ligand | 1 | 1995 | 69 | 0.030 |
Why?
|
| Cell Membrane | 1 | 1998 | 677 | 0.030 |
Why?
|
| Injections, Intraperitoneal | 1 | 2005 | 101 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 1997 | 690 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 1998 | 679 | 0.030 |
Why?
|
| Allergy and Immunology | 1 | 2014 | 13 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2005 | 307 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2005 | 397 | 0.030 |
Why?
|
| Freund's Adjuvant | 1 | 2014 | 26 | 0.030 |
Why?
|
| Antigens, Viral, Tumor | 1 | 1994 | 15 | 0.030 |
Why?
|
| Mice, Obese | 1 | 2014 | 44 | 0.030 |
Why?
|
| Lymphocyte Depletion | 2 | 2010 | 98 | 0.030 |
Why?
|
| Ovalbumin | 1 | 2014 | 109 | 0.030 |
Why?
|
| Computational Biology | 1 | 2017 | 551 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1994 | 323 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 1997 | 961 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 1995 | 919 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2005 | 486 | 0.030 |
Why?
|
| DNA Primers | 1 | 1994 | 543 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2005 | 1048 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2017 | 2360 | 0.030 |
Why?
|
| Radiotherapy | 1 | 2005 | 332 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2014 | 374 | 0.030 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2019 | 522 | 0.030 |
Why?
|
| Phenotype | 3 | 2010 | 2457 | 0.030 |
Why?
|
| Epitopes | 2 | 1990 | 254 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2005 | 1704 | 0.020 |
Why?
|
| Fibroblasts | 1 | 1994 | 759 | 0.020 |
Why?
|
| Aging | 1 | 1995 | 727 | 0.020 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2010 | 147 | 0.020 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2011 | 120 | 0.020 |
Why?
|
| CD3 Complex | 1 | 2010 | 134 | 0.020 |
Why?
|
| Pregnancy | 2 | 2011 | 3046 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 2015 | 979 | 0.020 |
Why?
|
| Autophagy-Related Protein 5 | 1 | 2010 | 11 | 0.020 |
Why?
|
| Radiation Chimera | 1 | 2010 | 23 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2016 | 1670 | 0.020 |
Why?
|
| 3T3-L1 Cells | 1 | 2009 | 34 | 0.020 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2009 | 25 | 0.020 |
Why?
|
| Autoantigens | 1 | 2010 | 129 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2010 | 371 | 0.020 |
Why?
|
| Gene Knock-In Techniques | 1 | 2009 | 29 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2010 | 223 | 0.020 |
Why?
|
| Intracellular Space | 1 | 2009 | 38 | 0.020 |
Why?
|
| Dietary Fats | 1 | 2009 | 135 | 0.020 |
Why?
|
| Embryonic Stem Cells | 1 | 2009 | 81 | 0.020 |
Why?
|
| Horseradish Peroxidase | 1 | 1988 | 35 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2010 | 563 | 0.020 |
Why?
|
| Blotting, Southern | 1 | 1988 | 127 | 0.020 |
Why?
|
| alpha-Fetoproteins | 1 | 1988 | 44 | 0.020 |
Why?
|
| Antibody Specificity | 1 | 1988 | 130 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2014 | 1731 | 0.020 |
Why?
|
| Kinetics | 2 | 2004 | 1534 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2010 | 557 | 0.020 |
Why?
|
| Mutation | 2 | 2017 | 4169 | 0.020 |
Why?
|
| CASP8 and FADD-Like Apoptosis Regulating Protein | 1 | 2007 | 13 | 0.020 |
Why?
|
| Cross Reactions | 2 | 2003 | 109 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2014 | 2887 | 0.020 |
Why?
|
| Tumor Necrosis Factor Ligand Superfamily Member 14 | 1 | 2006 | 14 | 0.020 |
Why?
|
| Resting Phase, Cell Cycle | 1 | 2006 | 5 | 0.020 |
Why?
|
| Lymphotoxin beta Receptor | 1 | 2006 | 29 | 0.020 |
Why?
|
| Prediabetic State | 1 | 2006 | 36 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2011 | 799 | 0.020 |
Why?
|
| Immunoglobulins | 1 | 2006 | 143 | 0.020 |
Why?
|
| Alleles | 1 | 2009 | 1137 | 0.020 |
Why?
|
| Adult | 2 | 2016 | 26836 | 0.020 |
Why?
|
| Immunoglobulin Allotypes | 1 | 1985 | 5 | 0.020 |
Why?
|
| Immunoglobulin kappa-Chains | 1 | 1985 | 96 | 0.010 |
Why?
|
| Complement System Proteins | 1 | 1984 | 82 | 0.010 |
Why?
|
| Mice, Inbred DBA | 1 | 2004 | 150 | 0.010 |
Why?
|
| Trans-Activators | 1 | 2007 | 443 | 0.010 |
Why?
|
| Interleukin-18 | 1 | 2004 | 26 | 0.010 |
Why?
|
| Interleukin-1 | 1 | 2004 | 72 | 0.010 |
Why?
|
| Cytotoxicity Tests, Immunologic | 1 | 2003 | 43 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2007 | 469 | 0.010 |
Why?
|
| Mitochondria | 1 | 2007 | 556 | 0.010 |
Why?
|
| Genes, env | 1 | 2002 | 8 | 0.010 |
Why?
|
| Neutralization Tests | 1 | 2003 | 80 | 0.010 |
Why?
|
| Homeodomain Proteins | 1 | 2007 | 559 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2007 | 837 | 0.010 |
Why?
|
| Milk | 1 | 2003 | 53 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 2002 | 97 | 0.010 |
Why?
|
| Lymphotoxin-beta | 1 | 2002 | 7 | 0.010 |
Why?
|
| Postpartum Period | 1 | 2004 | 153 | 0.010 |
Why?
|
| Genes, RAG-1 | 1 | 2002 | 13 | 0.010 |
Why?
|
| Neoplasms, Experimental | 1 | 1984 | 269 | 0.010 |
Why?
|
| Isoantigens | 1 | 2002 | 71 | 0.010 |
Why?
|
| Mammary Glands, Animal | 1 | 2003 | 80 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2002 | 137 | 0.010 |
Why?
|
| Sheep | 1 | 2002 | 251 | 0.010 |
Why?
|
| Chemokines | 1 | 2002 | 74 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2002 | 418 | 0.010 |
Why?
|
| Erythrocytes | 1 | 2002 | 254 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2003 | 1008 | 0.010 |
Why?
|
| DNA | 2 | 1989 | 1311 | 0.010 |
Why?
|
| Macromolecular Substances | 2 | 1995 | 177 | 0.010 |
Why?
|
| Incidence | 1 | 2004 | 1604 | 0.010 |
Why?
|
| Selection, Genetic | 1 | 2003 | 515 | 0.010 |
Why?
|
| Intracellular Fluid | 1 | 1997 | 34 | 0.010 |
Why?
|
| Subcellular Fractions | 1 | 1997 | 94 | 0.010 |
Why?
|
| Aged | 1 | 2014 | 19272 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2003 | 1380 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 1997 | 740 | 0.010 |
Why?
|
| Emetine | 1 | 1995 | 2 | 0.010 |
Why?
|
| HLA-DR Antigens | 1 | 1995 | 59 | 0.010 |
Why?
|
| Middle Aged | 1 | 2014 | 26173 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 1995 | 996 | 0.010 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1992 | 135 | 0.010 |
Why?
|
| Reserpine | 1 | 1989 | 5 | 0.010 |
Why?
|
| Vincristine | 1 | 1989 | 111 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 1989 | 258 | 0.010 |
Why?
|
| Lymphoma | 1 | 1989 | 266 | 0.000 |
Why?
|
| Killer Cells, Natural | 1 | 1989 | 276 | 0.000 |
Why?
|
| Immunity, Cellular | 1 | 1987 | 178 | 0.000 |
Why?
|
| RNA | 1 | 1989 | 583 | 0.000 |
Why?
|
| Immunoglobulin Constant Regions | 1 | 1985 | 21 | 0.000 |
Why?
|
| Mice, Inbred A | 1 | 1982 | 23 | 0.000 |
Why?
|